170 related articles for article (PubMed ID: 32862569)
1. Human Papilloma Virus infection and breast cancer development: Challenging theories and controversies with regard to their potential association.
Mastoraki A; Schizas D; Gkiala A; Ntella V; Hasemaki N; Pentara I; Ntomi V; Kapelouzou A; Liakakos T
J BUON; 2020; 25(3):1295-1301. PubMed ID: 32862569
[TBL] [Abstract][Full Text] [Related]
2. Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge?
Balci FL; Uras C; Feldman SM
Cancer Treat Res Commun; 2019; 19():100122. PubMed ID: 30785026
[TBL] [Abstract][Full Text] [Related]
3. Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China.
Li J; Ding J; Zhai K
PLoS One; 2015; 10(8):e0136050. PubMed ID: 26295705
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
[TBL] [Abstract][Full Text] [Related]
5. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
Singh Y; Shah A; Singh M; Verma S; Shrestha BM; Vaidya P; Nakarmi RP; Shrestha SB
Asian Pac J Cancer Prev; 2010; 11(3):615-7. PubMed ID: 21039025
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer.
Naushad W; Surriya O; Sadia H
Infect Genet Evol; 2017 Oct; 54():230-237. PubMed ID: 28705719
[TBL] [Abstract][Full Text] [Related]
8. Frequency of CD4+ regulatory T cells, CD8+ T cells, and human papilloma virus infection in Egyptian Women with breast cancer.
Tawfeik AM; Mora A; Osman A; Moneer MM; El-Sheikh N; Elrefaei M
Int J Immunopathol Pharmacol; 2020; 34():2058738420966822. PubMed ID: 33103515
[TBL] [Abstract][Full Text] [Related]
9. Papillomaviruses--to vaccination and beyond.
zur Hausen H
Biochemistry (Mosc); 2008 May; 73(5):498-503. PubMed ID: 18605974
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus disease and vaccines.
Hutchinson DJ; Klein KC
Am J Health Syst Pharm; 2008 Nov; 65(22):2105-12. PubMed ID: 18997137
[TBL] [Abstract][Full Text] [Related]
11. HPV vaccine update: new indications and controversies.
Mendoza N; Hernandez PO; Tyring SK
Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
[TBL] [Abstract][Full Text] [Related]
12. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
Mora-García ML; Monroy-García A
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?
Mandic A; Vujkov T
Ann Oncol; 2004 Feb; 15(2):197-200. PubMed ID: 14760108
[TBL] [Abstract][Full Text] [Related]
14. Hypothetic association between human papillomavirus infection and breast carcinoma.
Liang W; Tian H
Med Hypotheses; 2008; 70(2):305-7. PubMed ID: 17656036
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Methylenetetrahydrofolate Reductase C677T Polymorphism and Human Papilloma Virus Genotypes in Iranian Breast Cancer.
Rezaei H; Rassi H; Mansur FN
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):124-128. PubMed ID: 28537481
[TBL] [Abstract][Full Text] [Related]
16. Lack of Evidence for a Relationship between High Risk Human Papillomaviruses and Breast Cancer in Iranian Patients.
Doosti M; Bakhshesh M; Zahir ST; Shayestehpour M; Karimi-Zarchi M
Asian Pac J Cancer Prev; 2016; 17(9):4357-4361. PubMed ID: 27797244
[TBL] [Abstract][Full Text] [Related]
17. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
18. Human Papilloma Virus associated with oral cancer and preventive strategies: the role of vaccines.
Ottria L; Candotto V; Cura F; Baggi L; Arcuri C; Nardone M; Gaudio RM; Gatto R; Spadari F; Carinci F
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):61-65. PubMed ID: 29460519
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
20. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
